Bausch Health Cos., Inc. (BHC)
6.415
+0.10
(+1.50%)
USD |
NYSE |
Oct 20, 16:00
6.415
0.00 (0.00%)
After-Hours: 20:00
Bausch Health Cos. Enterprise Value : 22.27B for Oct. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 19, 2026 | 22.27B |
| October 16, 2026 | 22.27B |
| October 15, 2026 | 22.27B |
| October 14, 2026 | 22.11B |
| October 13, 2026 | 22.11B |
| October 12, 2026 | 22.13B |
| October 09, 2026 | 22.17B |
| October 08, 2026 | 22.17B |
| October 07, 2026 | 22.21B |
| October 06, 2026 | 22.16B |
| October 05, 2026 | 22.11B |
| October 02, 2026 | 22.08B |
| October 01, 2026 | 22.05B |
| September 30, 2026 | 22.09B |
| September 29, 2026 | 22.08B |
| September 28, 2026 | 22.07B |
| September 25, 2026 | 22.04B |
| September 24, 2026 | 22.02B |
| September 23, 2026 | 22.04B |
| September 22, 2026 | 22.08B |
| September 21, 2026 | 22.02B |
| September 18, 2026 | 22.03B |
| September 17, 2026 | 22.02B |
| September 16, 2026 | 22.04B |
| September 15, 2026 | 22.03B |
| Date | Value |
|---|---|
| September 14, 2026 | 22.12B |
| September 11, 2026 | 22.10B |
| September 10, 2026 | 22.18B |
| September 09, 2026 | 22.21B |
| September 08, 2026 | 22.31B |
| September 04, 2026 | 22.36B |
| September 03, 2026 | 22.44B |
| September 02, 2026 | 22.46B |
| September 01, 2026 | 22.33B |
| August 31, 2026 | 22.29B |
| August 28, 2026 | 22.27B |
| August 27, 2026 | 22.27B |
| August 26, 2026 | 22.34B |
| August 25, 2026 | 22.43B |
| August 24, 2026 | 22.41B |
| August 21, 2026 | 22.32B |
| August 20, 2026 | 22.46B |
| August 19, 2026 | 22.49B |
| August 18, 2026 | 22.50B |
| August 17, 2026 | 22.37B |
| August 14, 2026 | 22.34B |
| August 13, 2026 | 22.28B |
| August 12, 2026 | 22.23B |
| August 11, 2026 | 22.24B |
| August 10, 2026 | 22.28B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| InMed Pharmaceuticals, Inc. | 5.056M |
| NervGen Pharma Corp. | 102.70M |
| Milestone Pharmaceuticals, Inc. | 58.38M |
| Appili Therapeutics, Inc. | 10.20M |
| Clearmind Medicine, Inc. | -1.260M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 260.00M |
| Revenue (Quarterly) | 2.852B |
| Total Expenses (Quarterly) | 2.594B |
| EPS Diluted (Quarterly) | 0.6824 |
| Gross Profit Margin (Quarterly) | 65.04% |
| Profit Margin (Quarterly) | 9.12% |
| Earnings Yield | -46.15% |
| Operating Earnings Yield | 113.8% |
| Normalized Earnings Yield | 8.485 |